Goutelle

2024

Thèses

• PROFIL DE TOLÉRANCE DU LINÉZOLIDE EN HORS-AMM : ÉTUDE DE COHORTE CHEZ LES PATIENTS TRAITÉS POUR UNE INFECTION OSTÉO-ARTICULAIRE

2023

Publications

• Daptomycin Exposure as a Risk Factor for Daptomycin-Induced Eosinophilic Pneumonia and Muscular Toxicity

2022

Publications

• Daptomycin Physiology-Based Pharmacokinetic Modeling to Predict Drug Exposure and Pharmacodynamics in Skin and Bone Tissues

2021

Communications orales

• Challenge de la prise en charge des infections plurimicrobiennes
• Pharmacocinétiques et activités des antibiotiques libérés par les ciments

Posters

• CEFTAROLINE AND CEFTOBIPROLE: REAL LIFE OFF LABEL USE IN PATIENTS WITH BJI OF THESE TWO BETALACTAMS ACTIVE AGAINST METHICILLIN-RESISTANT STAPHYLOCOCCI
• Safety of tedizolid as suppressive antimicrobial therapy for patients with complex implant-associated bone and joint infection due to multidrug-resistant Gram-positive pathogens: results from the TediSAT cohort study

Publications

• Safety of Tedizolid as Suppressive Antimicrobial Therapy for Patients With Complex Implant-Associated Bone and Joint Infection due to Multidrug-Resistant Gram-Positive Pathogens: Results From the TediSAT Cohort Study
• Subcutaneous Antibiotic Therapy: The Why, How, Which Drugs and When
• Adherence to oral antibiotic therapy in patients with bone and joint infection: A pilot study
• Pharmacokinetic/Pharmacodynamic Dosage Individualization of Suppressive Beta-Lactam Therapy Administered by Subcutaneous Route in Patients With Prosthetic Joint Infection

2020

Publications

• Population pharmacokinetics of daptomycin in patients with bone and joint infection: minimal effect of rifampicin co-administration and confirmation of a sex difference
• Outpatient Subcutaneous Antimicrobial Therapy (OSCAT) as a Measure to Improve the Quality and Efficiency of Healthcare Delivery for Patients With Serious Bacterial Infections
• Medical innovations to maintain the function in patients with chronic PJI for whom explantation is not desirable: a pathophysiology-, multidisciplinary-, and experience-based approach
• Tolerance and Microbiological Efficacy of Cefepime or piperacillin/tazobactam in Combination With Vancomycin as Empirical Antimicrobial Therapy of Prosthetic Joint Infection: A Propensity-Matched Cohort Study

Formation continue et webinaires

• Place des dosages d’antibiotiques dans la PEC des IOA

2019

Posters

• Tolerance and microbiological efficacy cefepim or piperacillin/tazobactam in combination with vancomycin as empirical antimicrobial therapy of PJI
• Comparison of tolerance and microbiological efficacy of cefepim and piperacillin/tazobactam in combination with vancomycin as empirical antimicrobial therapy of prosthetic joint infection: a propensity-matched cohort study
• Comparaison de deux modèles pharmacocinétiques pour le suivi thérapeutique de la daptomycine
• Assessment of drug adherence to oral antibacterial therapy in bone and joint infections: a pilot study
• Implementation and validation of a pharmacokinetic model for Bayesian therapeutic drug monitoring of daptomycin in patients with bone and joint infection
• Observance au traitement antibiotique par voie orale dans les infections ostéo-articulaires : étude pilote
• Pharmacocinétique de la daptomycine dans les infections ostéo-articulaires : intérêt du suivi thérapeutique pharmacologique et de l’individualisation posologique

Publications

• Subcutaneous suppressive antibiotic therapy for bone and joint infections: safety and outcome in a cohort of 10 patients

2018

Thèses

• Étude pilote sur l’observance des antibiotiques administrés par voie orale dans les infections ostéo-articulaires

Publications

• Prospective Cohort Study of the Tolerability of Prosthetic Joint Infection Empirical Antimicrobial Therapy
• Population pharmacokinetics and probability of target attainment of ertapenem administered by subcutaneous or intravenous route in patients with bone and joint infection

2017

Thèses

• Analyse pharmacocinétique des populations de la daptomycine chez les patients atteints d’infections ostéo-articulaires

Posters

• Subcutaneous Suppressive Antibiotic Therapy for Bone and Joints Infections: Safety and Outcome in a Cohort of 10 Patients

Publications

• Mechanisms of drug-drug interaction between rifampicin and fusidic acid

2016

Posters

• Pharmacokinetics of Ertapenem Administered by Intravenous or Subcutaneous Route in Patients with Bone and Joint Infections: Population and Monte Carlo simulation study

Publications

• Pharmacokinetic Variability of Daptomycin during Prolonged Therapy for Bone and Joint Infections

2014

Communications orales

• Variabilité pharmacocinétique inter-individuelle et intra-individuelle de la daptomycine au cours du traitement des infections ostéo-articulaires complexes